The exclusion criteria
were patients diagnosed with lung cancer at earlier stages (I, II,
or III for patients with NSCLC and limited disease for patients
with SCLC), patients without a histological diagnosis of lung
cancer, patients currently treated with surgery, radiotherapy,
or chemotherapy, patients with brain metastases, and patients
with cognitive impairment.